A narrative review synthesizes the collagen biology behind vaginal laxity and the early clinical evidence for recombinant ...
The National Institutes of Health reports that in a controlled trial of chronic back pain with no identifiable physical cause, 66% of participants who received Pain Reprocessing Therapy (a talk ...
A comprehensive review details how three FDA-approved therapies have dramatically improved spinal muscular atrophy outcomes ...
ImmunityBio has secured early FDA label expansion for Anktiva in BCG-unresponsive NMIBC. Check out why IBRX stock is a hold.
Many people want to start strength training but don't know where to begin, or have tried in the past only to give up after ...
Tissue-friendly electrodes, developed by researchers at Lund University in Sweden, are now undergoing clinical trials at Skåne University Hospital ...
Absence of branched N-glycans on γδ T cells acts as a peripheral signal that amplifies a type 3/IL-17A response in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results